NCT05451485

Brief Summary

There is a wealth of evidence implicating the important role of blood flow throughout all stages of the process of atherogenesis. Two locations along the vascular tree at which atherosclerotic plaques are typically found are the carotid artery (CA) and the superficial femoral artery (SFA). Nowadays, ultrasound is the technique of choice for assessing the vascular condition in the CA and SFA. However, clinically used ultrasound techniques show a large variability in estimating the blood flow velocity, due to multiple limitations. With the advent of ultrafast ultrasound imaging, (almost) all elements of the transducer can be activated simultaneously. These so-called plane wave acquisition acquires thousands of images per second and makes continuous tracking of blood flow velocities in all directions in the field of view possible. This high-frame-rate acquisition opened up new possibilities for blood flow imaging at the CA and SFA, such as blood Speckle Tracking (bST) and ultrasound Particle Image Velocimetry (echoPIV). Both these vector flow imaging (VFI) techniques enable the quantification of 2D blood flow velocity profiles, where bST uses no contrast agents compared to echoPIV. Beside these novel ultrasound based techniques, 4D Phase Contrast Magnetic Resonance Imaging (4D flow MRI) enables a non-invasive quantification of the 4D blood flow velocity profiles (3D + time) and can be used as reference standard for blood flow assessments in-vivo. We therefore aim to evaluate the performance of both VFI techniques in comparison to 4D flow MRI measurements in the CA and SFA of healthy volunteers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 6, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 11, 2022

Completed
4 months until next milestone

Study Start

First participant enrolled

November 5, 2022

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 18, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 18, 2023

Completed
Last Updated

May 6, 2023

Status Verified

May 1, 2023

Enrollment Period

4 months

First QC Date

July 6, 2022

Last Update Submit

May 5, 2023

Conditions

Keywords

Vector Flow ImagingUltrasound Particle Image VelocimetryBlood Speckle Tracking4D flow MR

Outcome Measures

Primary Outcomes (2)

  • Validation VFI with MRI (echoPIV)

    Two-dimensional vector velocity fields derived from VFI (echoPIV) and 4D flow MRI will be used to calculate the spatiotemporal blood flow velocity profiles in artery

    1 day (no follow-up)

  • Validation VFI with MRI (bST)

    Two-dimensional vector velocity fields derived from VFI (bST) and 4D flow MRI will be used to calculate the spatiotemporal blood flow velocity profiles in artery

    1 day (no follow-up)

Secondary Outcomes (8)

  • Correlation VFI techniques (bST vs echoPIV)

    1 day (no follow-up)

  • Flow derived parameters (WSS)

    1 day (no follow-up)

  • Flow derived parameters (vorticity)

    1 day (no follow-up)

  • Flow derived parameters (vector complexity)

    1 day (no follow-up)

  • Old versus young (blood flow velocity profiles)

    1 day (no follow-up)

  • +3 more secondary outcomes

Study Arms (2)

Young volunteers

Volunteers with age between 20-30 years

Diagnostic Test: Blood speckle trackingDiagnostic Test: Ultrasound particle Imaging VelocimetryDiagnostic Test: 4D flow MRIDiagnostic Test: Conventional duplex

Old volunteers

Volunteers with age between 65-75 years

Diagnostic Test: Blood speckle trackingDiagnostic Test: Ultrasound particle Imaging VelocimetryDiagnostic Test: 4D flow MRIDiagnostic Test: Conventional duplex

Interventions

Blood speckle trackingDIAGNOSTIC_TEST

Blood speckle tracking measurements will be acquired of the carotid artery and superficial femoral artery

Old volunteersYoung volunteers

Ultrasound particle imaging velocimetry will be acquired of the carotid artery and superficial femoral artery

Old volunteersYoung volunteers
4D flow MRIDIAGNOSTIC_TEST

4D flow MRI will be acquired of the carotid artery and superficial femoral artery

Old volunteersYoung volunteers
Conventional duplexDIAGNOSTIC_TEST

Conventional duplex measurements will be acquired of the carotid artery and superficial femoral artery

Old volunteersYoung volunteers

Eligibility Criteria

Age20 Years - 75 Years
Sexall(Gender-based eligibility)
Gender Eligibility DetailsBoth young (n=10) and old (n=10) groups will exist of five female and five male subjects.
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The study population will include twenty healthy subjects divided in two different age groups. All volunteers will be recruited within Rijnstate hospital and Radboudumc.

You may qualify if:

  • Healthy male or female, without cardiovascular and pulmonary medical history and without the use of medication for cardiovascular risk factors
  • Age between 20-30 year or 65-75 years old
  • Willingness to undergo a 4D flow MRI scan and US examinations
  • Informed consent form understood and signed, and agrees to the hospital visit

You may not qualify if:

  • Hypersensitivity to the active substance(s) or any of the excipients in Sonovue
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rijnstate Hospital

Arnhem, Gelderland, Netherlands

Location

Related Publications (1)

  • Ruisch J, de Bakker JMK, van Helvert M, Schoonbrood MJP, Groot Jebbink E, Holewijn S, Reijnen MMPJ, de Korte CL, Saris AECM. Ultrasound-based Velocity Vector Imaging in the Carotid Bifurcation: Repeatability and an In Vivo Comparison With 4-D Flow MRI. Ultrasound Med Biol. 2025 Jun;51(6):969-976. doi: 10.1016/j.ultrasmedbio.2025.02.008. Epub 2025 Mar 6.

MeSH Terms

Conditions

Carotid Stenosis

Condition Hierarchy (Ancestors)

Carotid Artery DiseasesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesArterial Occlusive DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Michel Reijnen, MD, Prof

    Rijnstate Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 6, 2022

First Posted

July 11, 2022

Study Start

November 5, 2022

Primary Completion

March 18, 2023

Study Completion

March 18, 2023

Last Updated

May 6, 2023

Record last verified: 2023-05

Locations